October 2017

Features

Managing Chronic Pain: A Review of the CDC Guidelines

The CDC’s Guideline for Prescribing Opioids for Chronic Pain is intended for clinicians prescribing opioids for chronic pain outside of active cancer treatment, palliative care, and end-of-life treatment. 

New Drug Review 2017

Featured medications treat type 2 diabetes, two skin disorders, and severe asthma.

Overview of Gestational Diabetes

Gestational diabetes can increase the risk of pregnancy complications such as stillbirth, preeclampsia,  and macrosomia. 

Review of Selected NMEs 2017

Spotlighting new molecular entities that target HIV, hepatitis C, urothelial carcinoma, and chronic lymphocytic leukemia.

Sodium-Glucose Cotransporter 2 Inhibitors: An Overview

Improved understanding of the mechanisms involved in glucose reabsorption through the kidneys has led to the development of SGLT2 inhibitors.

Contemporary Compounding

Nebivolol HCl 2.5 mg/5 mL and Valsartan 40 mg/5 mL Oral Suspension

This liquid preparation may be used by patients who are unable to swallow solid tablets.

Editorial

Biosimilar Milestone

Does the first generic biologic cancer medication portend things to come?

Senior Care

U.S. Medical Product Integrity: Protecting Older Adults

To enhance global medical-product quality and supply-chain security, an FDA toolkit—one of many resources—addresses issues ranging from a drug‘s raw materials to its use by patients.

TrendWatch

Reporting and Consequences of Adverse Events

Medical errors are the third leading cause of death, and adverse events are one of the major causes of morbidity and mortality in healthcare.